BASF India Ltd Q2 FY2026 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/i8zf4ca27njzczg62rqb4kox.pdf

Key Takeaways


Top-Line & Profitability Drivers

Gerding: "I think it would not be fair to say that we see an immediate sort of hockey stick type improvement. Yeah, I think we have to be realistic here."

Nutrition & Care: The Bright Spot


Working Capital & Cash Flow


China Overcapacity & Pricing Environment

Gerding: "India has always done exceptionally well to run, to sweat the assets. Yeah, and to do smart incremental investments once the asset utilization has gone to a very healthy level."

Strategic Actions & Restructuring

Gerding: "The expected demerger completion timeline will be during the financial year 2627 and BASF will eventually be also listed on the stock exchanges."

Capex & Capacity Build-Out


Guidance & Commitments

CommitmentSpecificsTimeline
Receivables reductionBring receivables down further from current ₹3,000 crDecember quarter
Inventory controlBring inventory under controlNo specific date; confidence expressed
Ag solutions demerger completionOne-to-one share ratio; new entity listedDuring FY 2627
Coatings global transaction closeCarlyle 60%, BASF 40%; subject to regulatory approvalsQ2 calendar year 2026
Cellasto new facility commissioningNew facility ready; capacity improvement and import substitutionSecond half of 2026
Green energy savingsHybrid solar/wind captive agreement; Dahej and Panoli sites above 80% renewable25-year agreement signed
Cost structure post-demergerCore chemicals not burdened with extra functional platform costs currently absorbed by AgBy demerger completion

Key Metrics

MetricQ2 FY26
Revenue₹4,000 cr, down 5% YoY from ₹4,248 cr; volumes up 2%, prices down ~7%
Half-year revenue₹7,920 cr, down 4% YoY from ₹8,200 cr; volumes stable, prices down ~4%
PBT before exceptional items16% down YoY, 23% down QoQ; impacted by higher input costs and unfavorable product mix
Half-year PBT before exceptional items27% down YoY; PBT margin at 4.3% vs 5.6% last year
EPS before exceptional items₹56.5 (six months, not annualized)
Materials segment revenue~₹400 cr lower YoY (six months); monomers volumes down almost one-third
Nutrition & Care revenue₹1,700 cr (six months); volumes up ~8%, prices up 4%
Nutrition & Care PBT₹30 cr (six months), up 50% YoY from ₹20 cr; nutrition and health profits nearly doubled from ₹14 cr to ₹27 cr
Agriculture Solutions revenue~₹80 cr lower YoY (six months); impacted by wet monsoon, delayed and canceled spraying
Surface Technologies (Coatings) revenue₹280 cr (six months); higher volumes and price from key OEM customers
Industrial Solutions revenue₹1,400 cr (six months), stable; EBIT margin currently 5%
Net working capital₹2,500 cr vs ₹1,500 cr YoY; receivables down to ₹3,000 cr, accounts payable down ₹750 cr to ₹3,350 cr
Cash flow from operations-₹900 cr (six months); driven by lower accounts payable and higher receivables
Operating expenses (ex-COGS)13.2% of sales vs 11.5% YoY; higher employee costs, severance, SAP upgrade, and FX hedging costs
RoSI9.4% (six months, not annualized)
Return on net operating assets10.6% (six months, not annualized)
Receivable days65 days; 10–12% of receivables still under control